Case report: Complete pathological admission in N3 unresectable locally advanced lung adenocarcinoma with a novel INTS10-ALK and EML4-ALK fusion after neoadjuvant crizotinib - Zhai, Xiaoqian; Wang, Ting; Lin, Yiyun; Zhang, Jiabi; Wang, Yuqing; Wang, Weiya; Zhou, Qinghua; Zhu, Daxing (Frontiers in oncology, 2023)
Keywords: complete pathologic response; crizotinib; INTS10-ALK and EML4-ALK; lung cancer; neoadjuvant; Oncology; stage IIIB-N3; lung cancer; crizotinib; neoadjuvant; stage IIIB-N3; complete pathologic response; case report; INTS10-ALK and EML4-ALK